Olympia Biosciences™

UEMS Medical Specialties · MeSH-Tagged Dossiers · CDMO Science

Therapeutic R&D Intelligence Hub

91 formulation dossiers indexed across UEMS medical specialties and CDMO technology domains — each anchored in peer-reviewed evidence. Select your field below.

⌘Kto search any dossier

Smart Search

Find any dossier in seconds

Search by molecule, axis, challenge, category, or MeSH topic.

Try: bioavailability, PCOS, GLP-1, endotoxin, stability.

91

Published Dossiers

11

UEMS Specialties

5

CDMO Technology Domains

125M+

Papers in evidence review

Newest Research

Latest Publications

Formulation dossiers published most recently, sorted by date.

New

Human-in-the-Loop AI for Systematic Review in Food and Supplement Safety

Pharmaceutical and nutraceutical companies face a critical challenge in conducting efficient yet highly reliable evidence synthesis for food supplements and novel ingredients, balancing speed with the non-negotiable need for expert human judgment and regulatory compliance.

≈ 8 min read

Systematic ReviewArtificial Intelligence
View Dossier

Precision Microbiome & Gut-Brain Axis

Autonomic Stress Modulation by Nutraceutical, Microbiota-Directed, and Sensory Agents: An Evidence Synthesis with Pathway Map

Formulating nutraceuticals for reliable and context-specific autonomic stress modulation, particularly through gut-brain axis pathways, is challenging due to the variability in cardiac-vagal indices and the lack of robust, direct evidence for broad 'parasympathetic activation' claims.

≈ 6 min read

Autonomic Nervous SystemStress, Psychological
View Dossier

Precision Microbiome & Gut-Brain Axis

Evidence Review of Oral and Microbiota-Directed Bioactives for Cardiac Vagal Modulation and Physiological Relaxation

The primary challenge for formulators is to develop and substantiate 'vagus activating' or 'parasympathetic activating' ingredients with direct, robust human evidence of cardiac vagal modulation, moving beyond indirect stress markers that lack clinical specificity.

≈ 12 min read

Heart RateVagus Nerve
View Dossier

Catecholamine Homeostasis & Executive Function

Oral, Olfactory, and Topical Ingredients Modulating Cardiac Vagal Tone and Stress Physiology Biomarkers

Despite human evidence for various ingredients modulating cardiac vagal tone and stress physiology, significant challenges remain in establishing regulatory approval, with no EU or Polish approved health claims currently existing. Additionally, evidence strength varies substantially by ingredient and population, complicating product development and claim substantiation.

≈ 49 min read

Heart Rate VariabilityAutonomic Nervous System
View Dossier

Cerebral Bioenergetics & Neuro-Metabolic Rescue

Efficacy of Single-Ingredient Oral Supplements on Objective and Subjective Sleep Outcomes in Adult Insomnia

Developing single-ingredient oral supplements for insomnia faces challenges in achieving consistent objective efficacy due to variations in formulation standardization, optimal dosing, and specific population characteristics, leading to heterogeneous clinical outcomes.

≈ 23 min read

InsomniaSleep Aids, Non-Prescription
View Dossier

Catecholamine Homeostasis & Executive Function

Oral Bioactives for Sleep & Autonomic Function: Efficacy & Hot Beverage Sachet Delivery

Despite robust evidence for oral bioactives in capsules/tablets improving objective sleep and autonomic indices, there is a critical lack of formulation-specific data supporting their stability, bioavailability, and clinical efficacy when delivered via hot-beverage sachet formats.

≈ 49 min read

InsomniaSleep Initiation and Maintenance Disorders
View Dossier

Alphabetical Reference Index

Complete R&D Dossier Index

91 evidence-based formulation dossiers — click any title to access the full research article.

Evidence-Based Medicine

The Science of Formulation: Our Commitment to Evidence-Based Medicine

Olympia Biosciences™ is the brand of IOC sp. z o.o. This section explains how published research may inform a product brief; it is not a product-specific recommendation or performance claim.

Why We Publish Independent Scientific Literature

Published evidence and regulatory requirements vary by ingredient, dose, formulation and jurisdiction. Product-specific conclusions require review of the relevant evidence and applicable regulatory route.

A product-specific assessment considers the intended dose, formulation, evidence and regulatory requirements for its target market.

The scientific reviews published on this platform are general literature overviews, not assessments of specific commercial products.

Shape Our Research Agenda

Didn't find your research topic?

Submit a formulation science topic for consideration in the research agenda. We will notify you if a dossier is developed.

✓ Free ✓ Assessed by Olimpia Baranowska ✓ You'll be first to receive the dossier

Your data is used only to notify you when the dossier is published. No marketing emails.

Science Newsletter

New R&D Article Every Week

Get Olimpia's latest therapeutic research insights delivered straight to your inbox. B2B formulators & pharma scientists only.

No spam. Unsubscribe anytime. One email per week.

Our IP Pledge

Olympia has no brands of its own and never will – our business model rests on never competing with our clients.

Olympia has no brands of its own and never will – our business model rests on never competing with our clients.